Skip to main content
XWELL, Inc. (XWEL)
NASDAQ: XWEL · Real-Time Price · USD
1.170
-0.020 (-1.68%)
At close: Apr 28, 2026, 4:00 PM EDT
1.160
-0.010 (-0.85%)
After-hours: Apr 28, 2026, 4:03 PM EDT

XWELL Revenue

In the year 2025, XWELL had annual revenue of $29.21M, down -13.83%. XWELL had revenue of $7.15M in the quarter ending December 31, 2025, a decrease of -4.19%.

Revenue (ttm)
$29.21M
Revenue Growth
-13.83%
P/S Ratio
0.32
Revenue / Employee
$104,321
Employees
280
Market Cap
9.35M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202529.21M-4.69M-13.83%
Dec 31, 202433.90M3.79M12.58%
Dec 31, 202330.11M-25.83M-46.18%
Dec 31, 202255.94M-17.79M-24.13%
Dec 31, 202173.73M65.34M779.30%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Inotiv 514.03M
MDxHealth 107.88M
Biodesix 88.50M
Exagen 66.58M
Precipio 24.05M
bioAffinity Technologies 6.16M
iSpecimen 1.93M
Mainz Biomed 537.08K
Revenue Rankings

XWEL News

More News